Irvine, California 92612


Purpose:

The purpose of this is that the researcher can use low power Near Infrared laser treatment non-painful and non-damaging dose to changes the skin properties.The researcher can prove that signaling and a significant increase in the number of skin cells in skin tissue exposed to the laser can improve the human skin immune system to help improve human body response to vaccines.


Study summary:

The researcher can use low power laser light one-minute exposures delivered to the skin at non-painful and non-damaging dose. The resulted in significant immunologic changes in the skin that included up-regulation of specific skin tissue and skin genes and the activation and mobilization of specific skin cells. In the first part of the study, the researcher will make a determination of the laser irradiance that will be tolerated. The highest irradiance the subject tolerates for 1 minute will be identified as that subject's maximum tolerable irradiance. After all subjects are tested, researcher will select the highest irradiance that was tolerated and use this in the second phase of the study. Approximately 24 hours after the first test exposures, each subject will receive a one minute laser treatment at the maximum tolerable irradiance. Four hours later, two skin biopsies will be collected from laser treated site a untreated. One tissue sample will be test at UC Irvine Dept. of Dermatopathology to evaluate microscopic skin changes, one skin sample will be delivered to Massachusetts General Hospital to evaluate RNA and protein expression.


Criteria:

Inclusion Criteria: - Adult men and women with skin type 1 and 2 - Not pregnant Exclusion Criteria: - Use of systemic steroids, topical steroids, tanning solutions and anticoagulant - History of HIV, mentally incompetent, prisoner, alcohol or drug impairment - Abnormal photosensitivity


NCT ID:

NCT02453113


Primary Contact:

Principal Investigator
Kristen Kelly, MD
Beckman Laser Institute

Brent Martin, MD
Phone: 949.233-9060
Email: bcmartin@uci.edu


Backup Contact:

N/A


Location Contact:

Irvine, California 92612
United States

Brent Martin, MD
Phone: 949-233-9060
Email: bcmartin@uci.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.